B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Cd18 Antigens

23 PubMed studies analyzed ยท Evidence Score: 37.3

Research Domains

Cd18 Antigens has been studied across 9 research domains including ๐Ÿ›ก๏ธ Immunity, ๐Ÿ”ฌ Oncology, ๐Ÿ”ฌ Inflammation, โณ Longevity & Aging, ๐Ÿซ˜ Kidney. The primary research focus is ๐Ÿ›ก๏ธ Immunity with 17% of studies addressing this area.

Loading evidence profile...

This evidence profile for Cd18 Antigens is generated deterministically from 23 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.